BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berentsen S. How I treat cold agglutinin disease. Blood 2021;137:1295-303. [PMID: 33512410 DOI: 10.1182/blood.2019003809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Raes M, De Becker A, Blanckaert J, Balthazar T, De Ridder S, Mekeirele M, Verbrugge FH, Poelaert J, Taccone FS. Veno-venous extra-corporeal membrane oxygenation in a COVID-19 patient with cold-agglutinin haemolytic anaemia: A case report. Perfusion 2022;:2676591221127932. [PMID: 36128692 DOI: 10.1177/02676591221127932] [Reference Citation Analysis]
2 Krull A, Thompson T, Strasburg D, DiGuardo M, Jacob EK. How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease? Transfusion 2022. [PMID: 35946488 DOI: 10.1111/trf.17038] [Reference Citation Analysis]
3 Berentsen S, Barcellini W, D'Sa S, Jilma B. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom? Immunotherapy 2022. [PMID: 35946351 DOI: 10.2217/imt-2022-0085] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Berentsen S, Tjønnfjord GE. Current treatment options in cold agglutinin disease: B-cell directed or complement directed therapy? Transfusion Medicine Reviews 2022. [DOI: 10.1016/j.tmrv.2022.05.001] [Reference Citation Analysis]
5 Girard LP, Soekojo CY, Ooi M, Chng WJ, de Mel S. Immunoglobulin M Monoclonal Gammopathies of Clinical Significance. Front Oncol 2022;12:905484. [PMID: 35756635 DOI: 10.3389/fonc.2022.905484] [Reference Citation Analysis]
6 Fattizzo B, Barcellini W. Autoimmune hemolytic anemia: causes and consequences. Expert Rev Clin Immunol 2022;:1-15. [PMID: 35702053 DOI: 10.1080/1744666X.2022.2089115] [Reference Citation Analysis]
7 Gordon MJ, Ferrajoli A. Unusual complications in the management of chronic lymphocytic leukemia. Am J Hematol 2022. [PMID: 35491515 DOI: 10.1002/ajh.26585] [Reference Citation Analysis]
8 Gertz MA. Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2021.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Campbell A, Podbury B, Yue M, Mollee P, Bird R, Hapgood G. The Role of a Routine Bone Marrow Biopsy in Autoimmune Hemolytic Anemia for the Detection of an Underlying Lymphoproliferative Disorder. Hemasphere 2022;6:e674. [PMID: 34938958 DOI: 10.1097/HS9.0000000000000674] [Reference Citation Analysis]
10 Patriquin CJ, Pavenski K. O, wind, if winter comes … will symptoms be far behind?: Exploring the seasonality (or lack thereof) and management of cold agglutinin disease. Transfusion 2021. [PMID: 34893982 DOI: 10.1111/trf.16765] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Pasquale R, Giannotta JA, Barcellini W, Fattizzo B. Bortezomib in autoimmune hemolytic anemia and beyond. Ther Adv Hematol 2021;12:20406207211046428. [PMID: 34795889 DOI: 10.1177/20406207211046428] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Autore F, Pasquale R, Innocenti I, Fresa A, Sora' F, Laurenti L. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. Cancers (Basel) 2021;13:5804. [PMID: 34830959 DOI: 10.3390/cancers13225804] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Karki NR, McElhone P, Savage N, Abdel Karim N. Diagnosis and management of cold agglutinin disease associated with low-grade B-cell lymphoma in a patient receiving pembrolizumab for lung cancer. BMJ Case Rep 2021;14:e243751. [PMID: 34400426 DOI: 10.1136/bcr-2021-243751] [Reference Citation Analysis]
14 Pessach I, Dimopoulos MA, Kastritis E. Managing complications secondary to Waldenström's macroglobulinemia. Expert Rev Hematol 2021;:1-12. [PMID: 34170207 DOI: 10.1080/17474086.2021.1947236] [Reference Citation Analysis]
15 Albiol N, Moreno C. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies. Cancer J 2021;27:286-96. [PMID: 34398555 DOI: 10.1097/PPO.0000000000000537] [Reference Citation Analysis]
16 Lung T, Sakem B, Hemmerle A, Nydegger M, Risch M, Risch L, Nydegger U. Autoimmune diseases - New insights into a troublesome field. J Transl Autoimmun 2021;4:100108. [PMID: 34179743 DOI: 10.1016/j.jtauto.2021.100108] [Reference Citation Analysis]
17 Noto A, Cassin R, Mattiello V, Reda G. The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia. J Clin Med 2021;10:2064. [PMID: 34065833 DOI: 10.3390/jcm10102064] [Cited by in F6Publishing: 4] [Reference Citation Analysis]